Newron Pharmaceuticals Spa

0.00 (0.0%)

Newron Pharmaceuticals Financial Summary

The current 0QOI market cap is 220.92M. The company's latest EPS is -0.98 and P/E is N/A.

Year End 31 December 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 4.03M7.04M5.26M5.76M6.09M
Operating Income -14.66M-20.9M-18.07M-12.36M-13.3M
Net Income -15.04M-20.21M-21M-14.9M-17.49M
Year End 31 December 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 59.73M60.29M51.2M50.49M37.2M
Total Liabilities 4.89M23.49M33.95M47.38M51.23M
Total Equity 54.84M36.8M17.25M3.11M-14.03M
Year End 31 December 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating -16.11M-22.21M-15.59M-11.45M-11.09M
Investing 3.04M-932k-616k8.42M-317k
Financing 51k17.57M7.37M14.83M-186k
Market Cap 220.92M
Price to Earnings Ratio N/A
Price to Sales Ratio
Price to Cash Ratio
Price to Book Ratio
Dividend Yield -

Share Statistics

Shares Outstanding 17.85M
Average Volume (1 week) 1.1k
Average Volume (1 Month) 3.05k
52 Week Change 0.0%
52 Week High 12.38
52 Week Low 12.38
Spread (Intraday) 0 (0%)

Company Info

Company Name Newron Pharmaceuticals Spa
Address via antonio meucci 3, bresso
milan, lombardy 20091
Website https://www.newron.com
Industry pharmaceutical preparations (2834)
Your Recent History
Newron Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230529 18:09:24